As the World Health Organization conditionally recommends the use of GLP-1 medications to treat obesity, a Halifax-based ...

Paul Edison, MD, PhD, of Imperial College London, who wasn't involved with the studies, called the findings "an undeniable ...

Novo Nordisk has just released the topline findings from two eagerly anticipated phase 3 trials of its oral formulation of ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

Novo Nordisk is filing its supplemental new drug application (sNDA) for Wegovy 7.2 mg on the back of the phase 3b STEP UP ...

TB-500, and copper peptide to build muscle, rejuvenate skin, and boost longevity. But do they work and are they safe?

WHO’s new guidance supports Ozempic-class GLP-1 drugs for obesity treatment, but only alongside behavioural therapy and ...

WHO releases first global guideline on GLP-1 therapies for obesity treatment Obesity now affects over 1 billion people worldwide, driving millions of ...

As pharmaceutical companies rapidly expand direct-to-consumer (DTC) models amid shifting US drug pricing reforms and the upcoming launch of TrumpRx, experts warn that these approaches introduce as ...

The World Health Organization has published its first set of recommendations regarding medications for weight loss.

Uncover common misconceptions about GLP-1s for weight loss. Learn the importance of diet, exercise, managing side effects, ...

Phoenix, Arizona – December 02, 2025 – PRESSADVANTAGE – Phoenix NP announced an expansion of its service availability across Arizona to help more women access FDA-approved GLP-1 weight loss ...